The ADVIA 2120 hematology system: Flow cytometry-based analysis of blood and body fluids in the routine hematology laboratory

Laboratory Hematology

Volumn 11, Issue 1, 2005, Pages 47-61

  Harris, Neil ^a   Kunicka, Jolanta ^b   Kratz, Alexander ^c  

^a UNIVERSITY OF FLORIDA   (United States)

^b BAYER CORPORATION   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

ADVIA 120; ADVIA 2120; Automated cell analysis; Cell counters; Flow cytometry; Hematology analyzers

Indexed keywords

AUTOANALYZER; BLOOD ANALYSIS; BLOOD CELL COUNT; BODY FLUID; CEREBROSPINAL FLUID ANALYSIS; CYTOLYSIS; DEVICE; FETUS LUNG MATURITY; FLOW CYTOMETRY; HEMATOLOGY; HUMAN; LABORATORY; LEUKOCYTE; LEUKOCYTE COUNT; LIGHT SCATTERING; METHODOLOGY; RETICULOCYTE COUNT; REVIEW; STANDARD;

BLOOD CELL COUNT; BLOOD CHEMICAL ANALYSIS; BODY FLUIDS; BONE MARROW CELLS; DIAGNOSTIC TESTS, ROUTINE; ERYTHROCYTE COUNT; FLOW CYTOMETRY; HEMATOLOGY; HUMANS; OSMOTIC FRAGILITY; PLATELET COUNT; REPRODUCIBILITY OF RESULTS;

EID: 15944427129     PISSN: 10802924     EISSN: None     Source Type: Journal    
DOI: 10.1532/LH96.04075     Document Type: Review

References (62)

1. Morris MW Davey FR. Basic examination of blood. In: Henry JB, ed. Clinical Diagnosis and Management by Laboratory Methods. Philadelphia, Pa: W. B. Saunders; 2001:479-519.
2. Bollinger PB, Drewinko B, Brailas CD, Smeeton NA, Trujillo JM. The Technicon H*1 - an automated hematology analyzer for today and tomorrow: complete blood count parameters. Am J Clin Pathol. 1987;87:71-78.
3. Bain BJ. The Bayer Technicon series of automated haematology instruments. In: Brugnara C, von Kapff CT, eds. Bayer International Atlas of Hematology. Wilton, Conn: Chase Medical Communications; 1996:VII-XIII.
4. Brugnara C, Hipp MJ, Irving PJ, et al. Automated reticulocyte counting and measurement of reticulocyte cellular indices: evaluation of the Miles H*3 blood analyzer. Am J Clin Pathol. 1994; 102:623-632.
5. Tycko DH, Metz MH, Epstein EA, Grinbaum A. Flow cytometric light scattering measurement of red cell volume and hemoglobin concentration. Appl Optics. 1985;24:1355-1360.
6. Brugnara C. Use of reticulocyte cellular indices in the diagnosis and treatment of hematological disorders. Int J Clin Lab Res. 1998;28:1-11.
7. Malin MJ, Sclafani LD, Wyatt JL. Evaluation of 24-second cyanide-containing and cyanide-free methods for whole blood hemoglobin on the Technicon H*1TM analyzer with normal and abnormal blood samples. Am J Clin Pathol. 1989;92:286-294.
8. Benezra J. Mechanism of automated alkaline methods for the determination of hemoglobin in whole blood based on the micellization of ligated heme in the presence and absence of cyanide. Anal Chim Acta 1992;262:67-77.
9. Mohandas N, kim YR, Tycko DH, Orlik J, Wyatt J, Groner W. Accurate and independent measurement of volume and hemoglobin concentration of individual red cells by laser light scattering. Blood 1986;68:506-513.
10. Bononi A, Lanza F, Dabusti M, et al. Increased myeloperoxidase index and large unstained cell values can predict the neutropenia phase of cancer patients treated with standard dose chemotherapy. Cytometry. 2001;46:92-97.
11. Buttarello M, Bulian P, Venudo A, Rizzotti P. Laboratory evaluation of the Miles H*3 automated reticulocyte counter: a comparative study with manual reference method and Sysmex R-1000. Arch Pathol Lab Med. 1995;119:1141-1148.
12. Moritz A, Fickenscher Y, Meyer K, Failing K, Weiss DJ. Canine and feline hematology reference values for the ADVIA 120 hematology system. Vet Clin Pathol. 2004;33:32-38.
13. Kratz A, Ferraro M, Sluss PM, Lewandrowski KB. Case records of the Massachusetts General Hospital: weekly clinicopathological exercises: laboratory reference values. N Engl J Med. 2004; 351:1548-1563.
14. Bayer Health Care. ADVIA 2120 Operator's Guide V1.0.1.00, 2004. Tarrytown, NY: Bayer Health Care LLC, Diagnostics Division; 2004.
15. Van den Bossche J, Devreese K, Malfait R, et al. Reference intervals for a complete blood count determined on different automated haematology analysers: Abx Pentra 120 Retic, Coulter Gen-S, Sysmex SE 9500, Abbott Cell Dyn 4000 and Bayer Advia 120. Clin Chem Lab Med. 2002;40:69-73.
16. 2EDTA blood-drawing tubes for complete blood counts, reticulocyte counts, and white blood cell differentials. Lab Hematol. 2003;9:10-14.
17. Macey M, Azam U, McCarthy D, et al. Evaluation of the anticoagulants EDTA and citrate, theophylline, adenosine, and dipyridamole (CTAD) for assessing platelet activation on the ADVIA 120 hematology system. Clin Chem. 2002;48:6:891-899.
18. Giacomini A, Legovini P, Antico F, et al. Assessment of in vitro platelet activation by Advia 120 platelet parameters. Lab Hematol. 2003;9:132-137.
19. Brummitt DR, Barker HF. The determination of a reference range for new platelet parameters produced by the Bayer ADVIA 120 full blood count analyser. Clin Lab Haematol. 2000;22:103-107.
20. Ahnadi CE, Chapman ES, Lepine M, et al. Assessment of platelet activation in several different anticoagulants by the Advia 120 hematology system, fluorescence flow cytometry, and electron microscopy. Thromb Haemost. 2003;90:940-948.
21. Kunicka J, Fischer G, Zelmanovic D. Improved platelet count accuracy: two-dimensional platelet analysis. Am Clin Lab. 1998;17:6-7.
22. Van Cott EM, Fletcher SR, Kratz A. Effects of the material of the blood collection tube and of long-term storage on platelet activation parameters on the ADVIA 120/2120 Hematology System. Lab Hematol. 2005;11:71-75.
23. Macdougall IC, Cavill I, Hulme B, et al. Detection of functional iron deficiency during erythropoietin treatment: a new approach. BMJ. 1992;304:225-226.
24. Schaefer RM, Schaefer L. The hypochromic red cell: a new parameter for monitoring of iron supplementation during rhEPO therapy. J Perinat Med. 1995;23:83-88.
25. Macdougall IC. What is the most appropriate strategy to monitor functional iron deficiency in the dialysed patient on rhEPO therapy? Merits of percentage hypochromic red cells as a marker of functional iron deficiency. Nephrol Dial Transplant. 1998;13:847-849.
26. Locatelli F, Aljama P, Barany P, et al, for the European Best Practice Guidelines Working Group. Revised European best practice guidelines for the management of anemia in patients with chronic renal failure. Nephrol Dial Transplant. 2004;19(suppl 2):ii1-ii47; appendix B: assessment of iron stores and functional iron deficiency, ii39-ii41.
27. Ricerca BM, Storti S, d'Onofrio G, et al. Differentiation of iron deficiency from thalassaemia trait: a new approach. Haematologica 1987;72:409-413.
28. d'Onofrio G, Zini G, Ricerca BM, Mancini S, Mango G. Automated measurement of red blood cell microcytosis and hypochromia in iron deficiency and beta-thalassemia trait. Arch Pathol Lab Med. 1992;116:84-89.
29. Kutter D, Coulon N, Stirn F, Thoma M, Janecki J. Demonstration and quantification of "hyperchromic" erythrocytes by haematological analysers: application to screening for hereditary and acquired spherocytosis. Clin Lab. 2002;48:163-170.
30. Pati AR, Patton WN, Harris RI. The use of the Technicon H1 in the diagnosis of hereditary spherocytosis. Clin Lab Haematol. 1989;11:27-30.
31. Kunicka J, Malin M, Zelmanovic D, et al. Automated quantitation of hemoglobin-based blood substitutes in whole blood samples. Am J Clin Pathol. 2001;116:913-919.
32. Tsuchiya K, Okano H, Teramura M, et al. Content of reticulocyte hemoglobin is a reliable tool for determining iron deficiency in dialysis patients. Clin Nephrol. 2003;59:115-123.
33. Fishbane S, Galgano C, Langley RC Jr, Canfield W, Maesaka JK. Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients. Kidney Int. 1997;52:217-222.
34. Fishbane S, Shapiro W, Dutka P, Valenzuela OF, Faubert J. A randomized trial of iron deficiency testing strategies in hemodialysis patients. Kidney Int. 2001;60:2406-2411.
35. Tessitore N, Solero GP, Lippi G, et al. The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance crythropoietin. Nephrol Dial Transplant. 2001;16:1416-1423.
36. Thomas C, Thomas L. Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem. 2002;48:1066-1076.
37. Brugnara C, Zurakowski D, DiCanzio J, Boyd T, Platt O. Reticulocyte hemoglobin content to diagnose iron deficiency in children. JAMA. 1999;281:2225-2230.
38. Wu AC, Lesperance L, Bernstein H. Screening for iron deficiency. Pediatr Rev. 2002;23:171-178.
39. Kunicka JE, Fischer G, Murphy J, Zelmanovic D. Improved platelet counting using two-dimensional laser light scatter. Am J Clin Pathol. 2000;114:283-289.
40. Harrison P, Horton A, Grant D, Briggs C, MacHin S. Immunoplatelet counting: a proposed new reference procedure. Br J Haematol. 2000;108:228-235.
41. Giacomini A, Legovini P, Antico F, et al. Evaluation of platelet analysis on the ADVIA 120 hematology system. Lab Hematol. 2001;7:180-185.
42. Chapman ES, Sorette M, Hetherington E, et al. A rapid, automated flow cytometric method to measure activated degranulated platelets by density determination. Thromb Haemost. 2003; 89:1004-1015.
43. Macey MG, Carty E, Webb L, et al. Use of mean platelet component to measure platelet activation on the ADVIA 120 haematology system. Cytometry. 1999;38:250-255.
44. Giacomini A, Legovini P, Gessoni G, et al. Platelet count and parameters determined by the Bayer ADVIA 120 in reference subjects and patients. Clin Lab Haematol. 2001;23:181-186.
45. Kennon S, Price CP, Mills PG, et al. The central role of platelet activation in determining the severity of acute coronary syndromes. Heart. 2003;89:1253-1254.
46. Bae SH, Lee J, Roh KH, Kim J. Platelet activation in patients with diabetic retinopathy. Korean J Ophthalmol. 2003;17:140-144.
47. Ahnadi CE, Boughrassa FF, Chapman-Montgomery S, et al. Comparison of two methods to assess variability of platelet response to anti-platelet therapies in patients with acute coronary syndrome undergoing angioplasty. Thromb Haemost. 2004;92:1207-1213.
48. Brummitt DR, Barker HF, Pujol-Moix N. A new platelet parameter, the mean platelet component, can demonstrate abnormal platelet function and structure in myelodysplasia. Clin Lab Haematol. 2003;25:59-62.
49. Lim YA, Hyun BH. Evaluation of platelet parameters on the ADVIA 120 as the quality indicator for stored platelets. Clin Lab Haematol. 2002;24:377-384.
50. Zini G, d'Onofrio G. Neural network in hematopoietic malignancies. Clin Chim Acta. 2003;333:195-201.
51. D'Onofrio G. PANDA: innovative classification of hematopoietic malignancies. Bloodline Rev. 2001;1:3-6.
52. Winterbourn CC, Vissers MC, Kettle AJ. Myeloperoxidase. Curr Opin Hematol. 2000;7:53-58.
53. Lanza F. Clinical manifestation of myeloperoxidase deficiency. J Mol Med. 1998;76:676-681.
54. Leckie MJ, Bryan SA, Khan J, et al. Automated quantitation of circulating neutrophil and eosinophil activation in asthmatic patients. Thorax. 2000;55:471-477.
55. Biasucci LM, D'Onofrio G, Liuzzo G, et al. Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia. J Am Coll Cardiol. 1996;27:611-616.
56. Charuruks N, Voravud N, Sriuranpong V. MPXI and early neutrophilia: new potential therapeutic biomarkers for recombinant human granulocyte colony-stimulating factor. J Clin Lab Anal. 1998;12:41-46.
57. Tsakona CP, Goldstone AH. Patterns of primary degranulation as indicated by the mean myeloperoxidase index (MPXI) during bacteraemia in lymphoma transplants treated with growth factors. Clin Lab Haematol. 1992;14:273-280.
58. Aune MW, Becker JL, Brugnara C, et al. Automated flow cytometric analysis of blood cells in cerebrospinal fluid. Am J Clin Pathol. 2004;121:690-700.
59. Mahieu S, Vertessen F, Van der Planken M. Evaluation of ADVIA 120 CSF assay (Bayer) vs. chamber counting of cerebrospinal fluid specimens. Clin Lab Haematol. 2004;26:195-199.
60. Chapman JF, Ashwood ER, Feld R, Wu AH. Evaluation of two-dimensional cytometric lamellar body counts on the ADVIA 120 hematology system for estimation of fetal lung maturation. Clin Chim Acta. 2004;340:85-92.
61. Pedemonte MB, Shypula GJ, Hannon JS. Automated marrow analysis in the evaluation of hematologic malignancies [abstract]. Blood. 1999;94:211b. Abstract 0670.
62. Brugnara C, Laufer MR. Iron deficiency anemia: response to intravenous iron. In: Brugnara C, von Kapff CT eds. Bayer International Atlas of Hematology. Wilton, Conn: Chase Medical Communications; 1996:6-9.